Article Details

Equities Analysts Set Expectations for Sutro Biopharma, Inc.'s Q1 2022 Earnings (NASDAQ:STRO)

Retrieved on: 2022-03-06 06:53:47

Tags for this article:

Click the tags to see associated articles and topics

Equities Analysts Set Expectations for Sutro Biopharma, Inc.'s Q1 2022 Earnings (NASDAQ:STRO). View article details on hiswai:

Excerpt

Piper Sandler boosted their Q1 2022 EPS estimates for shares of Sutro Biopharma in a research report issued to clients and investors on Tuesday, ...

Article found on: forextv.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up